M
Michael D. Ross
Researcher at Beth Israel Deaconess Medical Center
Publications - 7
Citations - 1917
Michael D. Ross is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Apolipoprotein L1 & Kidney disease. The author has an hindex of 5, co-authored 7 publications receiving 1675 citations. Previous affiliations of Michael D. Ross include Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Giulio Genovese,Giulio Genovese,David J. Friedman,Michael D. Ross,Laurence Lecordier,Pierrick Uzureau,Barry I. Freedman,Donald W. Bowden,Carl D. Langefeld,Taras K. Oleksyk,Andrea L. Uscinski Knob,Andrea J. Bernhardy,Pamela J. Hicks,George W. Nelson,Benoit Vanhollebeke,Cheryl A. Winkler,Jeffrey B. Kopp,Etienne Pays,Martin R. Pollak,Martin R. Pollak +19 more
TL;DR: This article showed that focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22.
Journal ArticleDOI
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.
B. T Lee,Vineeta Kumar,Timothy A Williams,Reza Abdi,Andrea J. Bernhardy,Christine Dyer,S Conte,Giulio Genovese,Michael D. Ross,David J. Friedman,Robert S. Gaston,Edgar L. Milford,Martin R. Pollak,Anil Chandraker +13 more
TL;DR: It is concluded that APOL1 genotypes do not increase risk of allograft loss after kidney transplantations, and carrying 2 APol1 risk alleles should not be an impediment to transplantation.
Journal ArticleDOI
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines
Lijun Ma,Gregory S. Shelness,James A. Snipes,Mariana Murea,Peter A. Antinozzi,Dongmei Cheng,Moin A. Saleem,Simon C. Satchell,Bernhard Banas,Peter W. Mathieson,Matthias Kretzler,Ashok K. Hemal,Lawrence L. Rudel,Snezana Petrovic,Allison Weckerle,Martin R. Pollak,Michael D. Ross,John S. Parks,Barry I. Freedman +18 more
TL;DR: It is hypothesized that the higher levels of APOL1 protein in human cryosectioned podocytes may reflect both endogenous protein synthesis andAPOL1 uptake from the circulation or glomerular filtrate.
Journal ArticleDOI
Plasma Apolipoprotein L1 Levels Do Not Correlate with CKD
Leslie A. Bruggeman,John F. O’Toole,Michael D. Ross,Sethu M. Madhavan,Marlene Smurzynski,Marlene Smurzynski,K. Wu,Ronald J. Bosch,Samir K. Gupta,Martin R. Pollak,John R. Sedor,Robert C. Kalayjian +11 more
TL;DR: In this paper, the authors examined associations of APOL1 levels with plasma cytokine levels, dyslipidemia, and APOL 1 genotype in a nested case-control study (n=270) of HIV-infected African Americans.
Journal ArticleDOI
Podocyte injury induces nuclear translocation of WTIP via microtubule-dependent transport.
Jane H. Kim,Martha Konieczkowski,Amitava Mukherjee,Sam Schechtman,Shenaz Khan,Jeffrey R. Schelling,Michael D. Ross,Leslie A. Bruggeman,John R. Sedor +8 more
TL;DR: It is shown that WTIP translocated into podocyte nuclei in lipopolysaccharide (LPS)-treated mice, a model of transient nephrotic syndrome, suggesting a mechanism that transmits changes in podocyte morphology to the nucleus.